These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

397 related items for PubMed ID: 15093908

  • 1. 3D MRSI for resected high-grade gliomas before RT: tumor extent according to metabolic activity in relation to MRI.
    Pirzkall A, Li X, Oh J, Chang S, Berger MS, Larson DA, Verhey LJ, Dillon WP, Nelson SJ.
    Int J Radiat Oncol Biol Phys; 2004 May 01; 59(1):126-37. PubMed ID: 15093908
    [Abstract] [Full Text] [Related]

  • 2. Proton magnetic resonance spectroscopic imaging in newly diagnosed glioblastoma: predictive value for the site of postradiotherapy relapse in a prospective longitudinal study.
    Laprie A, Catalaa I, Cassol E, McKnight TR, Berchery D, Marre D, Bachaud JM, Berry I, Moyal EC.
    Int J Radiat Oncol Biol Phys; 2008 Mar 01; 70(3):773-81. PubMed ID: 18262090
    [Abstract] [Full Text] [Related]

  • 3. Patterns of recurrence analysis in newly diagnosed glioblastoma multiforme after three-dimensional conformal radiation therapy with respect to pre-radiation therapy magnetic resonance spectroscopic findings.
    Park I, Tamai G, Lee MC, Chuang CF, Chang SM, Berger MS, Nelson SJ, Pirzkall A.
    Int J Radiat Oncol Biol Phys; 2007 Oct 01; 69(2):381-9. PubMed ID: 17513061
    [Abstract] [Full Text] [Related]

  • 4. Metabolic imaging of low-grade gliomas with three-dimensional magnetic resonance spectroscopy.
    Pirzkall A, Nelson SJ, McKnight TR, Takahashi MM, Li X, Graves EE, Verhey LJ, Wara WW, Larson DA, Sneed PK.
    Int J Radiat Oncol Biol Phys; 2002 Aug 01; 53(5):1254-64. PubMed ID: 12128127
    [Abstract] [Full Text] [Related]

  • 5. Analysis of the spatial characteristics of metabolic abnormalities in newly diagnosed glioma patients.
    Li X, Lu Y, Pirzkall A, McKnight T, Nelson SJ.
    J Magn Reson Imaging; 2002 Sep 01; 16(3):229-37. PubMed ID: 12205577
    [Abstract] [Full Text] [Related]

  • 6. [Application of (1)H MR spectroscopic imaging in radiation oncology: choline as a marker for determining the relative probability of tumor progression after radiation of glial brain tumors].
    Lichy MP, Bachert P, Hamprecht F, Weber MA, Debus J, Schulz-Ertner D, Schlemmer HP, Kauczor HU.
    Rofo; 2006 Jun 01; 178(6):627-33. PubMed ID: 16703499
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Longitudinal multivoxel MR spectroscopy study of pediatric diffuse brainstem gliomas treated with radiotherapy.
    Laprie A, Pirzkall A, Haas-Kogan DA, Cha S, Banerjee A, Le TP, Lu Y, Nelson S, McKnight TR.
    Int J Radiat Oncol Biol Phys; 2005 May 01; 62(1):20-31. PubMed ID: 15850898
    [Abstract] [Full Text] [Related]

  • 9. Identification of MRI and 1H MRSI parameters that may predict survival for patients with malignant gliomas.
    Li X, Jin H, Lu Y, Oh J, Chang S, Nelson SJ.
    NMR Biomed; 2004 Feb 01; 17(1):10-20. PubMed ID: 15011246
    [Abstract] [Full Text] [Related]

  • 10. Improved delineation of brain tumors: an automated method for segmentation based on pathologic changes of 1H-MRSI metabolites in gliomas.
    Stadlbauer A, Moser E, Gruber S, Buslei R, Nimsky C, Fahlbusch R, Ganslandt O.
    Neuroimage; 2004 Oct 01; 23(2):454-61. PubMed ID: 15488395
    [Abstract] [Full Text] [Related]

  • 11. Delineation of target volume for radiotherapy of high-grade gliomas by 99m Tc-MIBI SPECT and MRI fusion.
    Krengli M, Loi G, Sacchetti G, Manfredda I, Gambaro G, Brambilla M, Carriero A, Inglese E.
    Strahlenther Onkol; 2007 Dec 01; 183(12):689-94. PubMed ID: 18040614
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of the lactate-to-N-acetyl-aspartate ratio defined with magnetic resonance spectroscopic imaging before radiation therapy as a new predictive marker of the site of relapse in patients with glioblastoma multiforme.
    Deviers A, Ken S, Filleron T, Rowland B, Laruelo A, Catalaa I, Lubrano V, Celsis P, Berry I, Mogicato G, Cohen-Jonathan Moyal E, Laprie A.
    Int J Radiat Oncol Biol Phys; 2014 Oct 01; 90(2):385-93. PubMed ID: 25104068
    [Abstract] [Full Text] [Related]

  • 13. MR-spectroscopy guided target delineation for high-grade gliomas.
    Pirzkall A, McKnight TR, Graves EE, Carol MP, Sneed PK, Wara WW, Nelson SJ, Verhey LJ, Larson DA.
    Int J Radiat Oncol Biol Phys; 2001 Jul 15; 50(4):915-28. PubMed ID: 11429219
    [Abstract] [Full Text] [Related]

  • 14. Comparison of magnetic resonance spectroscopy and perfusion-weighted imaging in presurgical grading of oligodendroglial tumors.
    Xu M, See SJ, Ng WH, Arul E, Back MF, Yeo TT, Lim CC.
    Neurosurgery; 2005 May 15; 56(5):919-26; discussion 919-26. PubMed ID: 15854239
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Usefulness of intraoperative ultra low-field magnetic resonance imaging in glioma surgery.
    Senft C, Seifert V, Hermann E, Franz K, Gasser T.
    Neurosurgery; 2008 Oct 15; 63(4 Suppl 2):257-66; discussion 266-7. PubMed ID: 18981831
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Magnetic resonance spectroscopic imaging for visualization of the infiltration zone of glioma.
    Stadlbauer A, Buchfelder M, Doelken MT, Hammen T, Ganslandt O.
    Cent Eur Neurosurg; 2011 May 15; 72(2):63-9. PubMed ID: 20635312
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.